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Abstract 
Arsenic is an environmental pollutant and its contamination in the drinking water is considered as a serious 
worldwide environmental health threat. The present study investigated the effects of arsenic exposure on 
antioxidant parameters and p53 expression in male albino rats. The animals (n=45) were exposed to arsenic (100 
ppm, 150 ppm and 200 ppm) for 4, 8 and 12 weeks as sodium arsenate in drinking water. Control animals (n=15) 
received distilled water for the same period. Hepatic superoxide dismutase (SOD), catalase, glutathione 
peroxidase (GPx), reduced glutathione (GSH), lipid peroxidation and total protein were evaluated 
spectrophotometrically. Expression of p53 was also detected by histochemical staining. Before the 
commencement of arsenic exposure, five animals were sacrificed to obtain baseline data. ANOVA followed by 
Tukey’s test was used to analyse the results with p<0.05 considered significant. Significant decrement in hepatic 
activities of SOD, catalase and GPx as well as hepatic concentration of GSH and total protein concentration 
characterized exposure to all the dose regimens of inorganic arsenic at all the time interval. Corroboratively, 
significant elevation was observed in malondialdehyde (MDA). The expression of p53 decreased in the groups 
that were exposed to arsenic as compared to the control animals. The findings from the present study suggests 
excessive generation of free radicals and reduction in p53 expression in arsenic – induced hepatotoxicity. 
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1.  Introduction 
Arsenic is a toxic metalloids, it exists in +5, +3, 0, and -3 oxidation states. It also exists in both organic and 
inorganic form in the environment. Arsenic in these four oxidation states is widely and ubiquitously distributed 
in the environment as a results of natural and anthropogenic activities in the environment. The +5 (arsenate) and 
+3 (arsenite) oxidation states are the most common forms of the natural occurring arsenic in the environment 
(Obinaju, 2009; Mateos et al., 2010, satyapal et al., 2018). The major cause of arsenic toxicity in human is due to 
exposure to contaminated drinking water from natural geological sources as most countries of the world have 
their drinking water contaminated with arsenic (Gebel, 2000; Matschullat, 2000; Zaw & Emett, 2002). Apart 
from drinking contaminated water, other form of exposure includes but not limited to; inhalation, absorption 
through the skin. Arsenicals may also enter food chain from agricultural products (Ratnaike, 2003). The major 
absorption site of arsenic in human is the ileum by an electrogenic process involving a proton gradient (Ratnaike 
& Barbour 2000), and are deposited in the skin, lungs, kidney, liver and heart. Lower amount of arsenic has 
however been reported have been observed in the muscles and neuronal tissues (Klaassen, 1996). Meanwhile, 
Flora et al. (2007) also reported that prolong exposure to arsenic for two to four weeks can also cause its 
incorporation into the nails and hair by binding to sulfhydryl groups of keratin.  
Arsenic inactivates approximately 200 enzymes involved in many important metabolic reactions such as 
cellular energy metabolism and DNA replication and repair with concomitant induction of plethora of diseases 
by oxidative stress, altered DNA methylation, altered DNA repair, mitochondrial damage, uncontrolled cell 
proliferation leading to promotion of tumourigenesis. Arsenicals can also substituted for phosphate in high 
energy compound such as ATP with concomitant consequences on energy metabolism of the cell (Ratnaike, 
2003; Butt & Rehman, 2011). 
The overall effectiveness of the electron transport chain notwithstanding, a small amount of electrons leak 
out of the respiratory chain and can therefore partially reduce oxygen to form reactive oxygen species (ROS) 
such as O2., H2O2 and –OH (Finsterer & Ohnsorge, 2013). These ROS are generated in normal cellular 
metabolism and signal transduction (Zhang et al., 2014). They can however cause oxidative damage to cellular 
macromolecules such as nucleic acids, proteins and lipids (Pace et al., 2017). Innate antioxidants such as SOD, 
catalase and glutathione peroxidase are the first line of defense against ROS effects. An amplified mitochondrial 
production of ROS and/or reduced intrinsic antioxidant capacity leads to an increased oxidative stress and are 
linked with a multitude of downstream effects as well as disease initiation and progression (Moskovitz et al., 
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) DOI: 10.7176/ALST 
Vol.75, 2019 
 
24 
2002). Similarly, previous studies have shown that p53, a tumor suppressor gene is an important transcription 
factor that regulates apoptosis, cell cycle progression and cellular senescence (Feridooni et al., 2011; Ma et al., 
2013). It is a well-established inducer of apoptosis, and it shows the most common genetic mutation found in 
cancers (Demirovic et al., 2014). Functionally, p53 therefore plays an important role in the maintenance of 
genomic stability (Rolland et al., 2007). 
Arsenic and its mechanisms of action has been the subject of reviews and symposia and its mechanism of 
action therefore is not yet completely understood (Flora et al., 2007). Although Ghosh et al. (2011) proposed 
free radical mediated theory to explain arsenic – induced catastrophes. In the present study however, we 
investigated the effects of low, intermediate and high doses of sodium arsenate exposure on hepatic redox status 
and the expression of p53 protein over a duration of 4, 8 and 12 weeks, aimed at proposing a possible 
mechanism for arsenic – induced hepatotoxicity. 
 
2. Materials and Methods 
2.1 Chemicals 
All chemicals used in this study were of the purest grade available and were obtained from the British Drug 
House (BDH) Chemicals Limited, Poole, England and Sigma-Aldrich, Missouri, U. S. A. 
 
2.2 Experimental animals 
Sixty five (65) male wistar rats obtained from the Animal house of the Faculty of Basic Medical Sciences, 
Ladoke Akintola University of Technology, Ogbomoso, with body weight ranging from 120 – 140 g were used 
for this study. They were housed in plastic cages and were acclimatized for 14 days before the commencement of 
arsenic exposure. They were allowed free access to standard rat pellet diet purchased from Vita Feeds Nigeria 
Limited and drinking water ad libitum. Animals were maintained at temperature of 29 ± 2°C and regular light-
dark cycle (06:00-18:00h) throughout the study. 
 
2.3 Study design 
At the commencement of the study, five (5) animals were sacrificed to obtain the baseline data. The remaining 
sixty (60) animals were randomly assigned into twelve (12) groups of five (5) animals each. Nine (9) groups 
were exposed to 100 ppm, 150 ppm and 200 ppm inorganic arsenic as disodium arsenate (Na2HAsO4) in their 
drinking water for four (4), eight (8) and twelve (12) weeks. The remaining three (3) groups served as control 
rats for each of the time intervals and received distilled water over the same period of time. 
 
2.4 Collection of organ 
The rats were fasted overnight at the end of arsenic exposure. The liver was quickly excised from the animals 
under light ether anesthesia. The liver was washed in ice cold 1.15% potassium chloride solution to remove 
blood stain and dried. A section of the liver was homogenized in phosphate buffer at pH 7.4 and centrifuged at 
5000 rpm for 10 min and was used for biochemical assays, while the other section of the liver was stored in 10% 
formalin and used for immuno – histochemical for p53 protein. 
 
2.5 Biochemical assays 
Determination of hepatic superoxide dismutase activity. Superoxide dismutase (SOD) was evaluated using 
Fortress diagnostic kit which employed the method described by Arthur (1985). Briefly, xanthine and xanthine 
oxidase are used to generate free radicals, which in turn react with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyl 
tetrazolium chloride (I.N.T) to form a red formazan dye. One unit of SOD is that which causes a 50% inhibition 
of the rate of reduction of I.N.T under the conditions of the assay.  
Determination of hepatic catalase activity. Hepatic catalase activity was assayed by the method of Sinha (1972). 
Determination of hepatic glutathione peroxidase activity. Hepatic glutathione peroxidase (GPx) activity 
was evaluated using the method of Rotruck et al. (1957).  
Reduced glutathione determination. The method described by Beutler et al. (1963) was employed in 
evaluating the level of reduced glutathione in the liver homogenate.  
Determination of hepatic MDA concentration. Lipid peroxidation was evaluated by measuring 
thiobarbituric reactive oxygen species (TBARS) in form of MDA using the method described by Varshney and 
Kale (1990).  
Total protein determination. Hepatic total protein concentration was determined according to the method of 
Biuret (1949). 
Immuno-histochemical assay. The immunochemical staining of liver for expressions of p53 was done 
according to the method of Chakravarthi et al. (2010), with slight modification. Slides were observed under a 
binocular microscope. Cells with specific brown colour in the cytoplasm, cell membrane or nuclei, depending on 
the antigenic sites, were considered positive. 
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2.6 Statistical analysis 
Results are expressed as mean ± SEM. One-way analysis of variance (ANOVA) followed by Tukey’s test was 
used to analyze the results with p < 0.05 considered significant. 
 
3. Results 
 
Fig 1: Hepatic SOD activity in rats exposed to different doses of inorganic arsenic. 
Exposure to 100, 150 and 200 ppm inorganic arsenic resulted in significant (p<0.05) reduction of hepatic 
superoxide dismutase activity (Fig. 1). The reduction in the activity of the enzyme was however time and dose 
dependent. At four weeks, exposure of the animals to 100 ppm produced 20% reduction in the activity of SOD in 
the liver however, when the dose and duration of exposure was increased to 200 ppm and 12 weeks respectively, 
the effect produced by the arsenic compound became 68%.   
 
Fig. 2: Hepatic Catalase Activity in rats exposed to different doses of inorganic arsenic. 
The mean hepatic catalase activity of the animals exposed to different doses of inorganic arsenic are 
depicted in fig. 2. Inorganic arsenic induced a significant (p<0.05) reduction in the activity of catalase in the 
liver. At the doses of 100 and 150 ppm, the reduction was time dependent up till 8 weeks. On the other hand, at 
200 ppm, the reduction in catalase activity was time dependent up till 12 weeks. At 4, 8 and 12 weeks, the effect 
of arsenic compound on the hepatic catalase activity was dose dependent. Exposure to 100 ppm arsenic for 4 and 
8 weeks caused about 26% reduction in the activity of the enzyme, while exposure to 200 ppm inorganic arsenic 
caused about 3 – fold reduction in the activity of hepatic catalase. 
 
Fig. 3: Hepatic GPx Activity in rats exposed to different doses of inorganic arsenic. 
The hepatic GPx activity as affected by exposure to sodium arsenate is depicted in fig. 3. When compared 
with the control, the hepatic GPx activity was significantly (p<0.05) decreased following exposure to 100, 150 
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and 200 ppm sodium arsenate for 4, 8 and 12 weeks. This observed decrement is most significant and dose 
dependent at 8 weeks. When compared with the control, 100, 150 and 200 ppm sodium arsenate caused a 31, 48 
and 55% decrease in the activity of the antioxidant enzyme respectively. Similarly, the response to the three 
doses of inorganic arsenate was also a dose dependent down – regulation of the activity of GPx in the 
hepatocytes. 
 
Fig. 4: Hepatic GSH concentration in rats exposed to different doses of inorganic arsenic. 
As illustrated in fig. 4, exposure to the three doses of sodium arsenate for 4, 8 and 12 weeks significantly 
(p<0.05) depleted hepatic GSH concentration at all doses and time interval. This depletion, which is dose 
dependent at four weeks is of magnitude 15, 46 and 64% respective for 100, 150 and 200 ppm. Similarly, this 
observed depletion in hepatic GSH concentration is also dose dependent at 12 weeks. At 12 weeks 100 ppm of 
the arsenicals reduced the GSH concentration in the liver by 62%, while 150 and 200 ppm caused 75 and 78% 
reduction in the hepatic GSH concentration.   
 
Fig. 5: Hepatic MDA concentration in rats exposed to different doses of inorganic arsenic. 
On exposure to sodium arsenate for 4, 8 and 12 weeks, (Fig. 5), a significant increase in hepatic MDA 
concentration characterized the observed effects. This observed elevation of product of lipid peroxidation, 
though not dose – dependent was time – dependent at all doses. At all dosage level, the least significant increase 
in hepatic MDA level was at 4 weeks, while exposure for 12 weeks induced the most significant increase when 
compared with the baseline data.   
 
Fig. 6: Hepatic total protein concentration in rats exposed to different doses of inorganic arsenic. 
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) DOI: 10.7176/ALST 
Vol.75, 2019 
 
27 
Figure 6 depicts the hepatic total protein concentration of arsenic – exposed animals. The arsenic compound 
at all dosage level and time interval induced a dose – and time – dependent decrease in hepatic total protein 
concentration. For instance, exposure to 100 ppm sodium arsenate for 4 weeks reduced the hepatic total level by 
26%, while exposure to 200 ppm of the same arsenate for 12 weeks reduced hepatic protein content by 61%. 
Immuno – histochemical Staining. 
 
Control 
 
100 ppm sodium arsenate 
 
150 ppm sodium arsenate 
 
200 ppm sodium arsenate 
Fig. 7; Expression of p53 in the liver of rats exposed to sodium arsenate for 4 weeks. Relative to the control 
groups, the arsenical down – regulated the expression of pro – apoptotic protein p53. Immunohistochemistry of 
the proteins revealed the presence of sparse protein staining in the hepatic gel of the animals exposed to sodium 
arsenate. In contrast, intense protein staining bserved in the control groups. 
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Control 
 
100 ppm sodium arsenate 
 
150 ppm sodium arsenate  
200 ppm sodium arsenate 
Fig. 8; Expression of p53 in the liver of rats exposed to sodium arsenate for 8 weeks. Relative to the control 
groups, the arsenical down – regulated the expression of pro – apoptotic protein p53. Immunohistochemistry of 
the proteins revealed the presence of sparse protein staining in the hepatic gel of the animals exposed to sodium 
arsenate. In contrast, intense protein staining was observed in the control groups. 
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Control  
 
100 ppm sodium arsenate 
 
150 ppm sodium arsenate 
 
200 ppm sodium arsenate 
Fig. 9; Expression of p53 in the liver of rats exposed to sodium arsenate for 12 weeks. Relative to the control 
groups, the arsenical down – regulated the expression of pro – apoptotic protein p53. Immunohistochemistry of 
the proteins revealed the presence of sparse protein staining in the hepatic gel of the animals exposed to sodium 
arsenate. In contrast, intense protein staining was observed in the control groups. 
 
4.  Discussion 
Several past studies have reported the very crucial roles of endogenous antioxidants in the effective mechanism 
of preventing free radicals – induced tissue damage (Elasoru et al., 2018). Examples of such endogenous 
antioxidants include SOD, Catalase, GPx and GSH. SOD is involved in the immediate transformation of 
superoxide anion (O2-) to hydrogen peroxide (H2O2). This process becomes very important in order to prevent 
O2- from participating in the reaction that leads to the formation of extremely pernicious hydroxyl radicals. The 
H2O2 is also a very potent oxidants and needs to be eliminated as fast as possible. The removal of H2O2 can be 
achieved by the activity of either catalase or GPx. Either of the two enzymatic antioxidants catalyzes the 
conversion of H2O2 to water (H2O). GSH in its own case functions as a source of electrons for GPx to reduce 
H2O2 to H2O (Peltola et al., 1992; Zini & Schlegel, 1996; Vaisberg et al., 2005). As shown in figs 1, 2, 3, and 4, 
the different doses (100 ppm, 150 ppm and 200 ppm) of inorganic arsenate for 4, 8 and 12 weeks resulted in a 
significant reduction in the activities of SOD, catalase and GPx as well as in the concentration of GSH in the 
liver. The reduction in the activity of SOD was time – and dose – dependent (Fig. 1). Meanwhile in the case of 
catalase, the decrement in the enzymic activity is most significant at 8 weeks (Fig. 2). The down – regulation of 
GPx activity by the arsenic species was also dose – dependent in each time interval (Fig. 3), and the most 
significant reduction in the activity was observed at 12 weeks. Similarly, the most significant effect of the 
arsenic specie on the concentration of GSH was by 200 ppm at 12 weeks (Fig. 4). The decrement in these 
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endogenous antioxidants observed in this study suggest an inorganic arsenic – induced swift depletion of stored 
antioxidants enzymes and protein. In view of this, it may be suggested that one of the major mechanisms through 
which inorganic arsenic induces its toxicity is through excessive generation of free radicals and therefore 
depletion of endogenous antioxidants. The above observation is in total agreement with the submissions of 
Hughes (2002); Pi et al. (2002); Kitchin and Ahmad (2003) who proposed that arsenic exert its toxicity chiefly 
by induction of free radicals formation.  
Lipid peroxidation is an accumulated effect of upsurge of free radicals production and failure of both the 
enzymatic and non – enzymatic antioxidants to either prevent the formation or scavenge the already formed free 
radicals. As a result of this, fatty acids in the cell are readily oxidized by reactive oxygen species (ROS) leading 
to the production of lipid peroxyl radicals. The lipid peroxyl radicals are then subsequently transformed into lipid 
peroxides in form of malondialdehyde (MDA) (Rao et al., 2001; Badmus et al., 2013). Initiation of lipid 
peroxidation may be by reactive oxygen species (ROS) with its ability to remove allylic hydrogen atom from a 
methylene group of polyunsaturated fatty acid side chains (Badmus et al., 2011). In the present study, as shown 
in fig. 5, significant elevation of MDA which is an end product of lipid peroxidation characterized the effects of 
exposure to inorganic arsenate at all doses and time intervals. This finding corroborates the reduced activities of 
SOD, catalase and GPx, as well as reduced GSH concentration observed in this study following exposure to the 
various dose regimens of inorganic arsenic. The observed increase in MDA concentration in the liver of the 
exposed animals is an indication of lipid peroxidation in the rats. This peroxidation process has been implicated 
in excessive damage, decrease membrane fluidity and exacerbation of the activities of various enzymes all of 
which are associated with degenerative disease, cancer, inflammation and ageing (Ames et al., 1993; Finkel et 
al., 2000; Elasoru et al., 2018). 
Fig. 6 depicts the hepatic total protein concentration. The figure indicates that all the three doses of arsenic 
significantly reduced the total protein concentration in the liver of the exposed animals when compared with the 
control animals. This reduction in hepatic protein concentration is time – and dose – dependent. Rooyackers et 
al. (1996) and Balagopal et al. (1997) have previously observed higher burden of free radicals causing imbalance 
in homeostatic phenomena between systemic oxidants and antioxidants in the down – regulation of muscle and 
mitochondria protein synthetic process, thus leading to decline in total cellular protein as observed in this study. 
This observation is consistent with the earlier findings in this study that the mechanism through which arsenic 
induces its toxic effects might be through excessive generation of free radicals, as well as, reducing the levels of 
antioxidant enzymes and proteins. Therefore, the finding from this study is suggestive of the fact that the lower 
hepatic total protein observed in this study is as a result of arsenic induced – oxidative stress, which previous 
studies have reported (Kataria et al., 1991; Welle et al., 1994; Ogundu et al., 2013). 
The oncoprotein p53 is a tumor suppressor protein and a phosphoprotein encoded by p53 gene (Megha et 
al., 2002). It functions as the “guardian of the genome” as it monitors the integrity of DNA during cell cycle by 
blocking the progression of cell with damaged or altered DNA to G1 phase of the cell cycle, giving room for 
genome repairing system. In a normal cell, the wild – type p53 present as an inactive latent form (Levine, 1997) 
is mainly expressed at moderate levels. This low basal level is usually maintained during cell cycle progression 
(Blagosklonny, 2002). However, during cellular or genotoxic stress, such as DNA damage, there is nuclear 
activation of the wild-type p53 gene (Volgelstein et al., 2000). Failure of the repairing system will make p53 to 
induce the expression of p21 protein which will in turn make the cell to die apoptotically. In this study, the under 
– expression of cytoplasmic p53 in all the treated groups relative to control groups, indicates that exposure to 
100 ppm, 150 ppm and 200 ppm inorganic arsenic even as early as at 4 weeks may significantly lower the 
physiologic p53-mediated apoptosis. In a study by Adeleke and Adaramoye (2017), using a different 
environmental toxicants, oxidative stress and down – regulation of p53 were both implicated in hepatotoxicity of 
experimental rats. 
On the basis of our findings, induction of oxidative stress and down – regulation of p53 protein expression 
could be an important mechanisms underlying inorganic arsenic – induced hepatotoxicity in rats. 
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